You know what absolutely cracks me up? When I’m talking to someone who I consider a smart investor (someone who reads annual reports for fun, who probably has Warren Buffett quotes hanging in their bathroom) and I tell them I’m buying the dip, they look at me like I just said I was putting my 401k into Dogecoin. Then come the classics: “How do you know this is the dip?” Or my personal favorite: “This economy is so bloated, this is just the beginning, man.”

I mean… come on. People said the exact same thing after the 2008 meltdown… which was way worse, by the way. Back then, you had entire banks collapsing, people losing jobs by the tens of thousands, and market sentiment so bleak you’d think we were entering the Great Depression 2.0. But anyone who actually bought back then? They’ve been laughing all the way to the bank… specifically the bank that didn’t get bailed out. From 2009 to today, the market is up 555%. That turns every $10k into $65k. And all you had to do was not listen to the “this is just the beginning” crowd. Anyway, rant over.

Speaking of buying low and maybe selling high enough to finally afford that $18 Big Mac combo… let’s talk about Owens & Minor. And in case you’re wondering, it’s not a hot AI play or some crypto-adjacent SPAC. It’s a boring old healthcare supply company based in Virginia. But boring can be beautiful… especially when the stock's scraping the bottom floor.

OMI is down 41% this year. Over the past 12 months? Try 71%. This thing’s been a full blown disaster. But I can’t ignore the fact that insiders are buying the heck out of it. Recently, Robert Sledd, the company’s Lead Director, dropped a fat $4.29 million at $8.17 a share. Coliseum Capital, which already owns 10%, threw in another $1.8 million.

The company itself is not sexy, but it’s essential. About three-quarters of their revenue comes from things like bandages, scalpels, and sterilization containers. The rest comes from in-home patient care… think diabetes support, CPAP machines, and all the stuff people actually use day-to-day. It’s a business that doesn’t go out of style, even in a recession. In fact, revenue is at an all-time high, hitting $10.7 billion in 2024. But yeah, they did post a hefty $363 million net loss (thanks in part to their $1.36 billion Rotech acquisition, which came with more debt than a med school graduate).

But the bones are solid. The CEO spent 15 years at Thermo Fisher, a company that went 10x under his watch. Since 1990, OMI’s posted a 13.5% return on capital employed. And with most of their production based in the U.S., they actually stand to benefit from Trump’s tariff.

On top of that, the options market is flashing some big, juicy signals. The Jun 2025 $1 puts have some of the highest implied volatility on the board right now. Which means traders are sensing something big is coming… either a rocket ship or a flaming ball of crap. Either way, it screams opportunity.

And if we’re just spitballing some numbers here: let’s say they grow revenue to $12.26 billion by 2027, which isn’t crazy. Assume a modest 1.5% free cash flow margin. Multiply that by 10, and you get a market cap around $1.85 billion. That’s a potential 260% return. Not bad for a stock most people wouldn’t touch with a ten-foot pole.

Look, Owens & Minor isn’t the kind of company that gets Reddit threads fired up. But the valuation’s in the basement, insiders are loading the boat, and if they can clean up the Rotech mess, this thing could quietly 2x or 3x before anyone even notices.

So yeah, maybe the economy’s one big never ending bubble. Maybe we’re all screwed. But the last time people were this scared, a whole generation of investors got rich.

Just something to think about before you roll your eyes at the next person buying the dip.

Stock.News does not have positions in companies mentioned.